Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study.

Neurooncol Adv · 2021 · PMC8086242 · PMID 33959716

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In all the years’ multivariate RMST regression fittings, MGMT methylation and extent of surgical resection remained highly significant while age, KPS, and enrollment in other trials also were found significant on patient survival in most results ( Table 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.